Last verified: April 2026

Vacha

वचा -- Vacha -- "speech; that which gives speech -- from Vach (to speak)"

Vacha is the classical herb of speech and cognition -- its name means 'speech' in Sanskrit, reflecting its primary documented action of clarifying and enhancing verbal expression and mental clarity. Charaka Samhita places Vacha in the Medhya (cognitive) and Kasahara groups. Its most characteristic classical use is as a Nasya (nasal) preparation -- Vacha powder blown into the nostrils is documented for acute Kapha conditions of the head and for bringing clarity of consciousness in conditions of mental dullness.

Important noticeThis page documents what classical texts record. Not medical advice. Consult a qualified practitioner. Full disclaimer

Charaka Samhita, Sutrasthana 4.9

Vacha medhya... svaranulomana -- Vacha is Medhya (cognitive-enhancing) and Svaranulomana (voice-normalising). It clears the vocal channels and the mental channels simultaneously -- the two classical systems through which 'speech' passes.

Classical documentation

Ashtanga Hridayam documents Vacha across: Unmada (mental disorders -- the Dhamapana Nasya with Vacha powder for acute Kapha-type mental dullness), Apasmara (seizure-type conditions), Svarabhedha (voice disorders), and Kasa (cough). The classical Vacha Ghrita is documented for cognitive impairment with Kapha dominance. Classical use in Ayurvedic child development tradition: Vacha paste applied to the tongue of infants is a documented practice in several regional traditions for promoting early speech development -- reflecting the classical Svaranulomana (voice-normalising) documentation.

Beta-asarone and regulatory status

Acorus calamus rhizome contains beta-asarone -- a compound documented as potentially mutagenic in animal studies at high doses. This has led to regulatory restrictions in several countries: the FDA (USA) banned A. calamus as a food additive in 1968; the EU restricts beta-asarone levels in food preparations. The Indian variety of Acorus calamus (Diploid -- 2n variety) has been documented as having significantly lower beta-asarone content than the North American and European tetraploid variety (which was used in the animal studies). API preparations use the Indian diploid variety. Classical preparations use the rhizome at traditional doses -- the safety profile at classical doses from the Indian variety is considered acceptable under the API framework. Self-administration of high-dose or non-Indian-variety preparations is not recommended.